Abstract

Objective: In recent years, the incidence of Bordetella pertussis infection in infants and young children has been increasing. Multiple studies have suggested that B. pertussis may be one of the pathogens of bronchiolitis in infants and young children. However, the prevalence and clinic characteristic of B. pertussis in bronchiolitis is controversial. This prospective descriptive study evaluated the prevalence and clinical manifestations of infants and young children hospitalized for bronchiolitis with B. pertussis.Methods: Children hospitalized with bronchiolitis were eligible for a prospective study for 36 months from January 1, 2017, to December 31, 2019. Besides B. pertussis, 10 common respiratory viruses and Mycoplasma pneumoniae (MP) were confirmed by laboratory tests. Medical records of patients were reviewed for demographic, clinical characteristics, and laboratory examination.Results: A total of 1,092 patients with bronchiolitis were admitted. B. pertussis was detected in 78/1,092 (7.1%) patients. Of the 78 patients with B. pertussis bronchiolitis, coinfections occurred in 45 (57.7%) patients, most frequently with human rhinovirus (28/78, 35.9%), followed by MP (9/78, 11.4%), and human bocavirus (6/78, 7.7%). The peak incidence of B. pertussis infection was in May. A high leukocyte count could help distinguish B. pertussis–associated acute bronchiolitis from other acute bronchiolitis etiologies. After excluding coinfections, children with B. pertussis–only bronchiolitis exhibited a milder clinical presentation than those with RSV-only infection; also, children with MP-only and other pathogen infections revealed similar severity. The morbidity of B. pertussis was common (31/78, 39.7%) in infants with bronchiolitis under 3 months.Conclusion: In summary, B. pertussis is one of the pathogens in children with bronchiolitis, and coinfection of B. pertussis with other viruses is common in bronchiolitis. B. pertussis should be considered when patients hospitalized with bronchiolitis present a longer course and have an elevated leukocyte count. Patients with B. pertussis–associated bronchiolitis present a milder clinical presentation.

Highlights

  • Pertussis, caused by the bacterium Bordetella pertussis, is a highly contagious respiratory disease and one of the leading causes of death from infectious diseases in children

  • A total of 40–80% of infection is caused by respiratory syncytial virus (RSV), followed by human rhinovirus (HRV), adenovirus (ADV), parainfluenza virus, human bocavirus, and human metapneumovirus [6, 7]

  • Of the total 1,092 patients admitted for bronchiolitis, one or more respiratory pathogens including virus and Mycoplasma pneumoniae (MP) were detected in 1,057 of 1,092 patients and B. pertussis was identified in 78 patients (7.1%, based on positive results by polymerase chain reaction (PCR))

Read more

Summary

Introduction

Pertussis, caused by the bacterium Bordetella pertussis, is a highly contagious respiratory disease and one of the leading causes of death from infectious diseases in children. The World Health Organization reported 141,074 confirmed pertussis cases worldwide in 2018 [2]. 160,700 deaths were reported worldwide in 2014 from pertussis in children

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call